Acute Effects of Added Sugar Intake on Cerebrovascular Function and Brain Integrity
1 other identifier
interventional
25
1 country
1
Brief Summary
This study will focus on acute effects of added sugars on brain health in a specific age group (30-64 years old). We will provide participants two meals (one meal containing 16 g of added sugars and the other containing 61 g of added sugars) and examine blood vessel function and brain structure using a MRI.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jun 2022
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 2, 2022
CompletedFirst Posted
Study publicly available on registry
June 7, 2022
CompletedStudy Start
First participant enrolled
June 14, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 17, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
April 17, 2023
CompletedMay 10, 2023
May 1, 2023
10 months
June 2, 2022
May 9, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (6)
Change from baseline in cerebrovascular reactivity at 3 hours post-consumption of each meal
% change in total cerebral perfusion measured using pseudo-continuous arterial spin labeling in response to 3-minutes of hypercapnia (+9 mmHg increase in PETCO2)
Over 2 weeks, at baseline and 3 hours post-consumption of each meal (low and high added sugar), separated by a 1-week washout
Change from baseline in hippocampal stiffness after 3 hours post-consumption of each meal
Magnetic Resonance Elastography (MRE) of the brain to assess hippocampal viscoelastic properties while the head will be vibrated using the Resoundant acoustic driver system
Over 2 weeks, at baseline and 3 hours post-consumption of each meal (low and high added sugar), separated by a 1-week washout
Change from baseline in hippocampal damping ratio at 3 hours post-consumption of each meal
Magnetic Resonance Elastography (MRE) of the brain to assess hippocampal viscoelastic properties while the head will be vibrated using the Resoundant acoustic driver system
Over 2 weeks, at baseline and 3 hours post-consumption of each meal (low and high added sugar), separated by a 1-week washout
Change from baseline in uric acid at 3 hours post-consumption of each meal
Blood biomarker of uric acid (e.g. serum uric acid)
Over 2 weeks, at baseline and 3 hours post-consumption of each meal (low and high added sugar), separated by a 1-week washout
Change from baseline in triglycerides at 3 hours post-consumption of each meal
Blood biomarker of triglycerides (e.g. serum triglycerides)
Over 2 weeks, at baseline and 3 hours post-consumption of each meal (low and high added sugar), separated by a 1-week washout
Change from baseline in oxidative stress at 3 hours post-consumption of each meal
Blood biomarker of oxidative stress (e.g. superoxide)
Over 2 weeks, at baseline and 3 hours post-consumption of each meal (low and high added sugar), separated by a 1-week washout
Secondary Outcomes (4)
Change from baseline in hippocampal cerebrovascular reactivity at 3 hours post-consumption of each meal
Over 2 weeks, at baseline and 3 hours post-consumption of each meal (low and high added sugar), separated by a 1-week washout
Changes from baseline in resting cerebral blood flow at 3 hours post-consumption of each meal
Over 2 weeks, at baseline and 3 hours post-consumption of each meal (low and high added sugar), separated by a 1-week washout
Change from baseline in other lipid profile at 3 hours post-consumption of each meal
Over 2 weeks, at baseline and 3 hours post-consumption of each meal (low and high added sugar), separated by a 1-week washout
Change from baseline in blood pressure at 3 hours post-consumption of each meal
Over 2 weeks, at baseline and 3 hours post-consumption of each meal (low and high added sugar), separated by a 1-week washout
Study Arms (2)
Low Added Sugar Meal
EXPERIMENTALParticipants will be provided a meal low in added sugars.
High Added Sugar Meal
EXPERIMENTALParticipants will be provided a meal high in added sugars.
Interventions
Consumption of a single 1,250 kcal meal containing 16 g of added sugars (5% of total energy)
Consumption of a single 1,250 kcal meal containing 61 g of added sugars (20% of total energy)
Eligibility Criteria
You may qualify if:
- Ability to provide informed consent;
- Men and women within the ages of 30-64 years;
- Habitual added sugar intake of \<150 kcal/day for men and \<100kcal/day for women;
- No allergies/intolerance to ingredients in the study meal (e.g., nuts, gluten)
You may not qualify if:
- Blood chemistries indicative of abnormal liver enzymes and renal function;
- Abnormal blood chemistry marker that is +/-2.5x the upper or lower limit;
- Chronic clinical diseases (e.g., coronary artery, peripheral artery, or cerebrovascular diseases, diabetes (type 1 and type 2), stages 5-6 chronic kidney disease, chronic obstructive pulmonary disease);
- Major psychiatric disorder (e.g. schizophrenia, bipolar disorder, major depression within past two years);
- Neurological or autoimmune conditions affecting cognition (e.g. Parkinson's disease, epilepsy, multiple sclerosis, head trauma with loss of consciousness greater than 30 min, large vessel infarct);
- Current medication use likely to affect central nervous system functions (e.g. long active benzodiazepines) and lipid-lowering medications (e.g., statins)
- Conditions which would contra-indicate MRI: implant of pacemakers or pacemaker wires; artificial heart valve; brain aneurysm surgery; middle ear implant; non-removable hearing aid or jewelry; braces; cataract surgery or lens implant; implanted mechanical or electrical device; foreign metallic objects in the body such as bullets, BBs, shrapnel, or metalwork fragments, claustrophobia;
- Current smoking;
- Pregnancy or breastfeeding
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Delaware
Newark, Delaware, 19713, United States
Study Officials
- STUDY DIRECTOR
Christopher Martens, PhD
University of Delaware
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 2, 2022
First Posted
June 7, 2022
Study Start
June 14, 2022
Primary Completion
April 17, 2023
Study Completion
April 17, 2023
Last Updated
May 10, 2023
Record last verified: 2023-05
Data Sharing
- IPD Sharing
- Will not share